Folgen
Ana B. Pavel
Titel
Zitiert von
Zitiert von
Jahr
PyElph-a software tool for gel images analysis and phylogenetics
AB Pavel, CI Vasile
BMC bioinformatics 13, 1-6, 2012
3372012
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a …
E Guttman-Yassky, PM Brunner, AU Neumann, S Khattri, AB Pavel, ...
Journal of the American Academy of Dermatology 78 (5), 872-881. e6, 2018
3022018
Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation
RD Sanyal, AB Pavel, J Glickman, TC Chan, X Zheng, N Zhang, I Cueto, ...
Annals of Allergy, Asthma & Immunology 122 (1), 99-110. e6, 2019
1712019
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
PM Brunner, AB Pavel, S Khattri, A Leonard, K Malik, S Rose, SJ On, ...
Journal of Allergy and Clinical Immunology 143 (1), 142-154, 2019
1622019
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
E Guttman-Yassky, AB Pavel, L Zhou, YD Estrada, N Zhang, H Xu, X Peng, ...
Journal of Allergy and Clinical Immunology 144 (2), 482-493. e7, 2019
1592019
Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis
H He, R Bissonnette, J Wu, A Diaz, ESC Proulx, C Maari, C Jack, M Louis, ...
Journal of Allergy and Clinical Immunology 147 (1), 199-212, 2021
1412021
Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis
E Guttman-Yassky, A Diaz, AB Pavel, M Fernandes, R Lefferdink, ...
JAMA dermatology 155 (12), 1358-1370, 2019
1292019
The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature
AB Pavel, L Zhou, A Diaz, B Ungar, J Dan, H He, YD Estrada, H Xu, ...
Journal of the American Academy of Dermatology 82 (3), 690-699, 2020
1162020
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24 …
B King, E Guttman-Yassky, E Peeva, A Banerjee, R Sinclair, AB Pavel, ...
Journal of the American Academy of Dermatology 85 (2), 379-387, 2021
1142021
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
AB Pavel, T Song, HJ Kim, E Del Duca, JG Krueger, C Dubin, X Peng, ...
Journal of Allergy and Clinical Immunology 144 (4), 1011-1024, 2019
1092019
Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial
R Bissonnette, AB Pavel, A Diaz, JL Werth, C Zang, I Vranic, VS Purohit, ...
Journal of Allergy and Clinical Immunology 144 (5), 1274-1289, 2019
1022019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
L Zhou, A Leonard, AB Pavel, K Malik, A Raja, J Glickman, YD Estrada, ...
Journal of Allergy and Clinical Immunology 144 (1), 144-156, 2019
1012019
A phase 2 randomized trial of apremilast in patients with atopic dermatitis
EL Simpson, S Imafuku, Y Poulin, B Ungar, L Zhou, K Malik, HC Wen, ...
Journal of Investigative Dermatology 139 (5), 1063-1072, 2019
992019
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic …
R Bissonnette, C Maari, S Forman, N Bhatia, M Lee, J Fowler, S Tyring, ...
British Journal of Dermatology 181 (4), 733-742, 2019
932019
Using enzymatic numerical P systems for modeling mobile robot controllers
AB Pavel, C Buiu
Natural Computing 11, 387-393, 2012
912012
Enzymatic numerical P systems-a new class of membrane computing systems
A Pavel, O Arsene, C Buiu
2010 IEEE Fifth International Conference on Bio-Inspired Computing: Theories …, 2010
902010
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease
PM Brunner, H He, AB Pavel, T Czarnowicki, R Lefferdink, T Erickson, ...
Journal of the American Academy of Dermatology 81 (2), 510-519, 2019
892019
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults
Y Renert-Yuval, E Del Duca, AB Pavel, M Fang, R Lefferdink, J Wu, ...
Journal of Allergy and Clinical Immunology 148 (1), 148-163, 2021
862021
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
B Ungar, AB Pavel, R Li, G Kimmel, J Nia, P Hashim, HJ Kim, M Chima, ...
Journal of Allergy and Clinical Immunology 147 (1), 394-397, 2021
862021
Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood
T Czarnowicki, H He, T Canter, J Han, R Lefferdink, T Erickson, S Rangel, ...
Journal of Allergy and Clinical Immunology 145 (1), 215-228, 2020
852020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20